000 01376 a2200421 4500
005 20250517201715.0
264 0 _c20180824
008 201808s 0 0 eng d
022 _a0031-7144
024 7 _a10.1691/ph.2017.7474
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZhou, Dan
245 0 0 _aRole of the endocannabinoid system in the formation and development of depression.
_h[electronic resource]
260 _bDie Pharmazie
_cAug 2017
300 _a435-439 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAntidepressive Agents
_xpharmacology
650 0 4 _aArachidonic Acids
_xpharmacology
650 0 4 _aCannabinoid Receptor Agonists
_xpharmacology
650 0 4 _aDepression
_xdrug therapy
650 0 4 _aEndocannabinoids
_xmetabolism
650 0 4 _aHumans
650 0 4 _aPolyunsaturated Alkamides
_xpharmacology
650 0 4 _aReceptor, Cannabinoid, CB1
_xagonists
700 1 _aLi, Yue
700 1 _aTian, Tian
700 1 _aQuan, Wei
700 1 _aWang, Lei
700 1 _aShao, Qing
700 1 _aFu, Lian-Qiang
700 1 _aZhang, Xiao-Hong
700 1 _aWang, Xiao-Ye
700 1 _aZhang, Hui
700 1 _aMa, Yan-Min
773 0 _tDie Pharmazie
_gvol. 72
_gno. 8
_gp. 435-439
856 4 0 _uhttps://doi.org/10.1691/ph.2017.7474
_zAvailable from publisher's website
999 _c28084303
_d28084303